Literature DB >> 11820863

Hepatoprotective activity of Achyrocline satureioides(Lam) D. C.

C Kadarian1, A M Broussalis, J Miño, P Lopez, S Gorzalczany, G Ferraro, C Acevedo.   

Abstract

Aerial parts of Achyrocline satureioides(Lam) D. C. (Asteraceae) are used in folk medicine as infusions or decoctions for the management of several diseases including gastrointestinal and hepatic disorders. These data and the presence of flavonoids and caffeoyl derivatives have led us to study its hepatoprotective and choleretic activities. The hepatoprotective activity was evaluated in the bromobenzene- (BB-) induced hepatotoxicity model in mice through the measurement of the serum levels of alanine-aminotransferase (ALT) and aspartate transaminase (AST), thiobarbituric acid reacting substances (TBARS) and glutathione levels. The aqueous extract of the aerial parts of A. satureioides administered before BB, at the dose of 300 mg kg(-1)p.o., demonstrated significant inhibition (P< 0.01) in the BB increase of liver ALT and AST and in the BB-induced increase of liver TBARS content. Also it was able to significantly increase (P< 0.05) the depleted levels of liver glutathione. In addition, at the same dose, a significant increase (P< 0.01) in the bile flow of rats was found. The results obtained with the aqueous extract of A. satureioides support its use in popular medicine as a hepatoprotective and digestive agent, and the effects might be mediated through the antioxidant and choleretic activities. Copyright 2002 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11820863     DOI: 10.1006/phrs.2001.0904

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  6 in total

1.  Effect of Tridax procumbens on liver antioxidant defense system during lipopolysaccharide-induced hepatitis in D-galactosamine sensitised rats.

Authors:  Vilwanathan Ravikumar; Kanchi Subramanian Shivashangari; Thiruvengadam Devaki
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

2.  Indigenous traditional medicine: in vitro anti-giardial activity of plants used in the treatment of diarrhea.

Authors:  Clara Lia Costa Brandelli; Raquel Brandt Giordani; Geraldo Attilio De Carli; Tiana Tasca
Journal:  Parasitol Res       Date:  2009-01-20       Impact factor: 2.289

3.  Hydroalcoholic Extract from Inflorescences of Achyrocline satureioides (Compositae) Ameliorates Dextran Sulphate Sodium-Induced Colitis in Mice by Attenuation in the Production of Inflammatory Cytokines and Oxidative Mediators.

Authors:  Luisa Mota da Silva; Jaime Antonio Machado Farias; Thaise Boeing; Lincon Bordignon Somensi; Ana Paula Beber; Benhur Judah Cury; José Roberto Santin; Sérgio Faloni de Andrade
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-25       Impact factor: 2.629

4.  Supplementation with Achyrocline satureioides Inflorescence Extracts to Pregnant and Breastfeeding Rats Induces Tissue-Specific Changes in Enzymatic Activity and Lower Neonatal Survival.

Authors:  Karla Suzana Moresco; Alexandre Kleber Silveira; Carlos Eduardo Schnorr; Fares Zeidán-Chuliá; Rafael Calixto Bortolin; Leonardo da Silva Bittencourt; Moara Mingori; Luana Heimfarth; Thallita Kelly Rabelo; Maurilio da Silva Morrone; Juliana Poglia Carini; Daniel Pens Gelain; Valquiria Linck Bassani; José Cláudio Fonseca Moreira
Journal:  Biomedicines       Date:  2017-08-29

5.  Design and Synthesis of Flavonoidal Ethers and Their Anti-Cancer Activity In Vitro.

Authors:  Lu Jin; Meng-Ling Wang; Yao Lv; Xue-Yi Zeng; Chao Chen; Hai Ren; Heng Luo; Wei-Dong Pan
Journal:  Molecules       Date:  2019-05-06       Impact factor: 4.411

6.  Achyrocline satureioides (Lam.) D.C. Hydroalcoholic Extract Inhibits Neutrophil Functions Related to Innate Host Defense.

Authors:  Eric Diego Barioni; José Roberto Santin; Isabel Daufenback Machado; Stephen Fernandes de Paula Rodrigues; Viviane Ferraz-de-Paula; Theodoro Marcel Wagner; Bruno Cogliati; Matheus Corrêa Dos Santos; Marina da Silva Machado; Sérgio Faloni de Andrade; Rivaldo Niero; Sandra Helena Poliselli Farsky
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-11       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.